PT Prodia Diacro Laboratories Receives Frost & Sullivan’s 2026 Southeast Asian Contract Research Organization Customer Value Leadership Recognition for Customer-Centric Clinical Research Excellence
Prodia the CRO is recognized for its reliable, integrated clinical research ecosystem, customer-centric delivery model, and commitment to quality, innovation, and long-term sponsor value across Southeast Asia. SAN ANTONIO, Sept. 8, 2026 /PRNewswire/ -- Frost & Sullivan is pleased to announce that PT Prodia Diacro Laboratories (Prodia the CRO) has received the 2026 Southeast Asian Customer Value Leadership Recognition in the...
Taiwan’s HORIEN Accelerates Global Footprint: Achieves Three Thai FDA Class 4 Approvals and Secures U.S. Patent for Biodegradable Ureteral Stent
Market-entry initiative targets qualified Thai distributors across dental, surgical, wound-care, and regenerative medicine channels, while solidifying global IP leadership in advanced urological biomaterials. TAICHUNG, Sept. 8, 2026 /PRNewswire/ -- HORIEN Biochemical Technology Co., Ltd. (TPEx: 7814) today announced a major double milestone in its global expansion strategy: the formal entry into the Thai market following Thai Food and...
Huawei and Partners Jointly Launch Four AI+ Healthcare Scenarios Solution across APAC
SINGAPORE, Sept. 7, 2026 /PRNewswire/ -- HIMSS26 APAC a flagship digital health event for the Asia-Pacific region at Marina Bay Sands Expo and Convention Centre in Singapore. During the event, Huawei hosted the "AI for Health, Health for All" forum, bringing together more than 100 healthcare leaders, experts, and partners from across APAC. At the forum, Huawei and...
Cell Stem Cell: tBE-mediated Base Editing Therapy Achieves Durable Clinical Remission in Sickle Cell Disease and β-Thalassemia Across Different Genetic Backgrounds
Following 100% transfusion independence in Chinese TDT patients, new study confirms tBE is equally safe and effective for African SCD patients and TDT patients from South/Southeast Asia. SHANGHAI, Sept. 8, 2026 /PRNewswire/ -- On September 7, 2026, Shanghai, Cell Stem Cell published online clinical research from CorrectSequence Therapeutics (Correctseq) in collaboration with multiple institutions in a paper titled "Clinical base...
U.S. District Court Invalidates Kaneka’s Ubiquinol Patent, Clearing the Way for Cocrystal Tech’s CrysQnol™ in the U.S. Market
Judge Overturns Kaneka's '080 Patent for Lack of Utility and Enablement, Removing Legal Uncertainty for Customers and Partners JIAXING, China, Sept. 7, 2026 /PRNewswire/ -- Cocrystal Technology (Jiaxing) Co., Ltd. ("Cocrystal Tech") today announced that the U.S. District Court for the Eastern District of New York has ruled in the company's favor in its long-running patent dispute with Kaneka...
Ministry of Food and Drug Safety of Korea, Successfully Concludes ‘GBC 2026,’ Marking a Great Leap in Bio
– 5,600 participants from 19 countries discuss global bio innovation and the path forward – – Strengthened global regulatory cooperation, with a total of 23 meetings held with overseas regulators and industry, including 5 regulatory cooperation meetings – SEOUL, South Korea, Sept. 7, 2026 /PRNewswire/ -- This is an article published in The Korea Herald: The Ministry of...
Nature Biotechnology | Insilico’s AI-Driven IPF Candidate Rentosertib Shows Potential for Biological Age Reversal, as Assessed by Six Proteomic Aging Clocks
First-in-Class Evaluation of an AI-Driven Candidate: This is the first de-novo drug designed with generative AI for a de-novo target discovered using AI and Aging Research (AI aging clocks, AI models and Hallmarks of Aging Assessment). First Universal Consensus Across Six Independently-Developed Proteomic Aging Clocks: Analyzing 12-week longitudinal Olink proteomic data from 42 IPF patients, six aging...
CelluPro Receives EXCiPACT™ Certification for GMP-grade Cell Culture Media Manufacturing, Strengthening Global Biomanufacturing Supply Capabilities
YANTAI, China, Sept. 7, 2026 /PRNewswire/ -- CelluPro, a biotechnology company specializing in serum-free cell culture media and bioprocess solutions, has achieved EXCiPACT™ GMP Certification for Pharmaceutical Auxiliary Materials (PAMs), becoming the first Chinese cell culture media supplier to receive EXCiPACT™ certification. EXCiPACT™ is an internationally recognized certification scheme for pharmaceutical auxiliary materials, establishing GMP requirements for materials used...
Prof Kevin Plaxco joins Nutromics as Chief Scientific Officer, bolstering expansion efforts for the DNA-based sensing platform
MELBOURNE, Australia, Sept. 7, 2026 /PRNewswire/ -- Nutromics, a Melbourne-based startup leading the frontier of DNA-based sensing, has announced the appointment of Professor Kevin W. Plaxco as Chief Scientific Officer (CSO). The company is preparing for the launch of its first product in 2027, while simultaneously extending its wearable platform to other targets. This extension is where Professor...
Rznomics Reports Major Advances in High-Efficiency Circular RNA Production in Nucleic Acids Research
SEONGNAM, South Korea, Sept. 7, 2026 /PRNewswire/ -- Rznomics Inc.(KOSDAQ: 476830), a biopharmaceutical company specializing in the development of RNA-based gene therapies, announced a major breakthrough in the high-efficiency production of circular RNA (circRNA) – a rapidly emerging modality in next-generation RNA therapeutics. The research was published online in Nucleic Acids...
